Delivery Order SPE2DB24D2205-SPE2DB25FEGHT
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Viscoat Syringes (0.5 mL), valued at $3,087.53. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,825.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Viscoat Syringes in 0.5ml quantities. The delivery order, which closes on July 24, 2025, represents a competitively awarded contract with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14,627.79 delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on August 11, 2025, with a completion date of August 12, 2025. The contract employs firm fixed pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,066.90 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes in 0.5ML configuration. This competitive, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of July 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT syringes. The $5,065.40 firm-fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $7,238.88 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of "VISCOAT SYRINGE 0.5ML", a medical supply product, with a completion date of July 11, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order worth $4,083.45 for the supply of Viscoat Syringes 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 21, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,565.34 firm-fixed-price contract is for the delivery of 0.75 mL VISCOAT syringes. This award is under a larger Indefinite Delivery Contract valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $2,835.96, this order is for the supply of 0.75ml VISCOAT SYRINGES to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by October 31, 2023. No set-aside designation was applied to this award. As a...
- This $21,290.28 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 mL VISCOAT syringes. The order has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities supporting...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGHTDelivery Order
The Defense Logistics Agency awarded a $2,628.99 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Viscoat syringes (0.5mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies medical products and pharmaceuticals to federal military and veteran healthcare systems through the DLA Medical Supply Chain. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving federal healthcare customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/15/25 |